Expertise in
2
conditions

Gerd-rudiger R. Burmester

Charité Universitätsmedizin
Berlin, BE, DE 
Expertise in
2
conditions
Charité Universitätsmedizin
Berlin, BE, DE 

Overview

Gerd-rudiger Burmester practices practicing medicine in Berlin, Germany.

Mr. Burmester is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Arthritis, Rheumatoid Arthritis (RA), Reactive Arthritis, Systemic Lupus Erythematosus (SLE), and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 98 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Charité Universitätsmedizin
Berlin, BE, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: October 12, 2023
Intervention Type: Drug
Study Drugs: Olokizumab, Methotrexate
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

98 Total Publications

Daratumumab in systemic lupus erythematosus: a single-arm phase 2 trial.
Daratumumab in systemic lupus erythematosus: a single-arm phase 2 trial.
Journal: Nature communications
Published: July 11, 2025

Frequently Asked Questions about Gerd-rudiger R. Burmester

Is Gerd-rudiger R. Burmester a top-rated expert for Arthritis?

MediFind is an objective health platform that identifies experts based on real-world data. Gerd-rudiger R. Burmester is classified as an Advanced expert for Arthritis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Gerd-rudiger R. Burmester participate in research or clinical trials?

Yes. Gerd-rudiger R. Burmester has published 98 articles and abstracts on conditions like Arthritis. You can view a list of Gerd-rudiger R. Burmester's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Burmester's expertise for a condition
ConditionClose
      View All 27 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile